Penicillin G Potassium Injection, Powder, For Solution
Product Images NDC 51662-1709

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Penicillin G Potassium (NDC 51662-1709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51662 1709 Source)

Label for Penicillin G Potassium Injection, USP, 5,000,000 units per vial, a powder for solution. The label specifies usage for intramuscular or intravenous injection, includes dosage form details, lot and expiration placeholders, and is manufactured by Sagent Pharmaceuticals, Schaumburg, IL, made in Italy. The NDC prefix visible is 25021.*

FDA Label Image

Structure (51662 1709 Structure)

Chemical structure diagram of penicillin G potassium showing its molecular framework, including a beta-lactam ring and side chains characteristic of this antibiotic.*

FDA Label Image

Table (51662 1709 Table 1)

A data table listing clinical indications alongside their corresponding infecting organisms targeted by Penicillin G Potassium injection. It details conditions like septicemia, anthrax, diphtheria, syphilis, and meningitis with specific bacterial pathogens such as Streptococcus pyogenes, Bacillus anthracis, Corynebacterium diphtheriae, Treponema pallidum, and Neisseria meningitidis. The table also notes that Penicillin G is not the first choice for gram-negative bacillary infections.*

FDA Label Image

Table (51662 1709 Table 2)

A dosage chart listing clinical indications and corresponding dosage information for Penicillin G Potassium injection powder. It details unit doses per day and treatment duration for infections such as serious streptococcal diseases, anthrax, actinomycosis, diphtheria, syphilis, meningitis, and others, indicating administration routes intramuscular and intravenous where relevant.*

FDA Label Image

Table (51662 1709 Table 3)

A data table presenting clinical indications and corresponding dosage information for penicillin G potassium injection powder for solution. Conditions include serious infections like pneumonia and meningitis, disseminated gonococcal infections, arthritis, endocarditis, syphilis, diphtheria, and rat-bite fever, with specified unit dosages and dosing intervals for each.*

FDA Label Image

Table (51662 1709 Table 4)

A data table presenting approximate desired concentrations (units/mL) and corresponding volumes (in mL) for Penicillin G Potassium injection powder for solution. It includes values for approximate volume, solvent volume for a 5,000,000 unit vial, and infusion-only volume for 20,000,000 units.*

FDA Label Image

Label (51662 1709 1 Rfid)

A packaging label for PENICILLIN G POTASSIUM injection powder for solution, distributed by HF Acquisition Co., LLC in Mukilteo, WA. The label includes a barcode, text indicating to see the manufacturer's insert, and a code stating RX ONLY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.